跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,721 条关于
“IL-15 superagonist”
全部
9,721
临床试验
2,772
药物
1,073
机构
128
资讯
5,748
10个月前
Forlong Biotechnology Initiates Phase 2 Trial of IL-15 Superagonist FL115 Combined with BCG for Non-Muscle Invasive Bladder Cancer
11个月前
Forlong Biotechnology Receives Milestone Payment as Partner's Fbody® Fusion Protein Therapy Advances to IND Submission
10个月前
Calidi Biotherapeutics Advances CLD-401 Oncolytic Virus Therapy Toward IND Filing in Q4 2026
去年
ANKTIVA Receives Permanent J-Code from CMS, Streamlining Reimbursement for Bladder Cancer Treatment
去年
ImmunityBio Partners with Saudi Arabia to Bring FDA-Approved Cancer BioShield Platform to Middle East
去年
ImmunityBio and BeiGene Collaborate on Phase 3 Trial of ANKTIVA and Tislelizumab in NSCLC
5个月前
ImmunityBio Secures $100 Million in Financing to Support Global Expansion of ANKTIVA Immunotherapy
6个月前
ImmunityBio Achieves Manufacturing Breakthrough for NK Cell Therapy Platform with Scalable Production Process
去年
FDA Approvals in 2024: Novel Therapies for MASH, WHIM Syndrome, Pediatric Glioma, MDS, and Bladder Cancer
8个月前
ImmunityBio's CD19 CAR-NK Therapy Achieves 15-Month Complete Response in Waldenström Lymphoma
第 1 页,共 575 页
上一页
下一页